loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 0cdf3f67 5bf3 4d58 B330 03febdc652bf Applno 203049 Form Injectable Injection Dosage 250mg 2 5ml 100mg Ml - Drug Product Composition: Argatroban

    Menu

    Argatroban

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 86,526Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 203049 / DOSAGE - INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML)

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ARGATROBAN(UNII: IY90U61Z3S)
    (ARGATROBAN ANHYDROUS - UNII:OCY3U280Y3)     		ARGATROBAN ANHYDROUS250mg in 2.5 | 50mg in 50

    Inactive Ingredients

    Ingredient Name
    Amneal Pharmaceuticals LLC
    Glaxo Operations UK Ltd
    GlaxoSmithKline LLC
    Hikma Pharmaceuticals USA Inc.
    Novartis Pharmaceuticals Corporation
    Par Pharmaceutical, Inc.
    ALCOHOL(3K9958V90M)
    PROPYLENE GLYCOL(6DC9Q167V3)     
    SODIUM CHLORIDE(451W47IQ8X)     
    SORBITOL(506T60A25R) 
    WATER(059QF0KO0R)